Form 4: Olema Pharma COO Gifts 75,000 Shares to Family Trust

Olema Pharmaceuticals' Chief Operating and Financial Officer, Shane Kovacs, transferred 75,000 shares of common stock as a bona fide gift to a family trust.

Summary

• Shane William Charles Kovacs, Chief Operating & Financial Officer of Olema Pharmaceuticals, Inc. (OLMA), disposed of 75,000 shares of common stock.
• The transaction occurred on December 8, 2025, and was classified as a gift (Transaction Code G).
• The shares were transferred to the Kovacs 2025 Family Trust for no consideration ($0 price per share).
• Following this transaction, Mr. Kovacs directly beneficially owns 243,549 shares of Olema Pharmaceuticals common stock.
• Mr. Kovacs explicitly stated that he does not have voting, dispositive, or pecuniary interest over any of the securities held by the trust.

Sentiment

Score: 5

Explanation: The transaction is a bona fide gift by an officer to a family trust, with the officer disclaiming control. This is a neutral event for the company's operational performance or stock valuation.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This Form 4 filing details a routine insider transaction (a gift of shares) and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• Shane Kovacs, Chief Operating & Financial Officer, transferred 75,000 shares of common stock to the Kovacs 2025 Family Trust as a bona fide gift for no consideration.

Stakeholder Impact

• Shareholders will note a change in the direct beneficial ownership of a key executive, with 75,000 shares moving to a family trust where the executive disclaims control.

Key Dates

Keywords

Olema Pharmaceuticals, OLMA, Shane Kovacs, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, Officer Transaction